Table 2 Data of stage IB1 and IIA1 patients before and after matching
Variables | Unmatched | Matched | ||||
|---|---|---|---|---|---|---|
R-CT (n = 321) | RH (n = 3755) | p-value | R-CT (n = 300) | RH (n = 300) | p-value | |
Age (years) | 58.9 ± 10.8 | 48.0 ± 9.8 | 0.000 | 57.7 ± 10.0 | 57.5 ± 9.8 | 0.874 |
FIGO stage | 0.000 | 1.000 | ||||
IB1 | 84 (26.2%) | 2770 (73.8%) | 81 (27.0%) | 81 (27.0%) | ||
IIA1 | 237 (73.8%) | 985 (26.3%) | 219 (73.0%) | 219 (73.0%) | ||
Histological type | 0.000 | 1.000 | ||||
SCC | 308 (96.0%) | 3350 (89.2%) | 288 (96.0%) | 288 (96.0%) | ||
AC | 9 (2.8%) | 310 (8.3%) | 8 (2.7%) | 8 (2.7%) | ||
SAC | 4 (1.2%) | 95 (2.5%) | 4 (1.3%) | 4 (1.3%) | ||
Tumour size | 0.000 | 1.000 | ||||
> 4 cm | 60 (18.7%) | 470 (12.5%) | 58 (19.3%) | 58 (19.3%) | ||
≤ 4 cm | 261 (81.3%) | 3285 (87.5%) | 242 (80.7%) | 242 (80.7%) | ||